Electroencephalographic Signatures of Methylphenidate in ADHD: A Systematic Review and 10 Recommendations for Future Research

OBJECTIVE: Methylphenidate is the first-line treatment for ADHD, yet its neurocognitive mechanisms remain incompletely understood. Electroencephalography (EEG) has been used to examine methylphenidate’s effects on brain function and has been proposed as a potential tool for monitoring treatment response. This systematic review addressed whether EEG can (a) clarify methylphenidate’s neurocognitive mechanisms and (b) serve as a biomarker of treatment response.

via https://pubmed.ncbi.nlm.nih.gov/42708537/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20260920010907&v=2.20.1